Back to Trials
NCT05054413RecruitingAccepts Healthy Volunteers

Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

M.D. Anderson Cancer Center

Start Date

4/15/2021

Completion Date

8/1/2030

Summary

This study formulates consensus agreement on clinical key elements related to prostate cancer care that are critical for standardization and global reported using a robust Delphi technique, completely remote and electronic. The goal of this survey study is to have a panel of specialty-specific experts create a consensus agreement on a minimum set of key data elements for use in standardized reports. These recommendations would be used to develop standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivorship.

Detailed Description

PRIMARY OBJECTIVE: I. To formulate consensus agreement on a minimum set of clinical key elements that should be included in standardized reports in electronic health records when managing patients with prostate cancer. OUTLINE: Participants complete 3-4 rounds of questionnaires over 20-30 minutes each over 2 weeks.

Eligibility Criteria

Age Range: 21 years to No maximum

Inclusion Criteria: * Age 21 and above * Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology * Maintenance of an active practice that includes prostate cancer patients * English speaking Exclusion Criteria: * Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer * Prisoners, children, and adults unable to consent to participation will also be excluded * No exclusions were made based on sex, age, racial/ethnic background, or pregnancy status

Interventions

OTHER

Questionnaire Administration

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Locations

M D Anderson Cancer Center

Houston, Texas 77030

United States